This brand name is authorized in Austria, Australia, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Japan, Lithuania, Netherlands, Poland, United Kingdom, United States
The drug INTUNIV contains one active pharmaceutical ingredient (API):
|
1
Guanfacine
UNII PML56A160O - GUANFACINE HYDROCHLORIDE
|
|
Guanfacine is a selective alpha2A-adrenergic receptor agonist in that it has 15-20 times higher affinity for this receptor subtype than for the alpha2B or alpha2C subtypes. Guanfacine is a non-stimulant. The mode of action of guanfacine in ADHD is not fully established. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| INTUNIV Prolonged-release tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C02AC02 | Guanfacine | C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AC Imidazoline receptor agonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 11440D, 11441E, 11451Q, 11452R |
| Country: CA | Health Products and Food Branch | Identifier(s): 02409100, 02409119, 02409127, 02409135 |
| Country: EE | Ravimiamet | Identifier(s): 1697159, 1697160, 1697171, 1697182, 1697193, 1697216, 1697227, 1697238, 1697249 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1151040002, 1151040004, 1151040006, 1151040008 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 074927, 118421, 185859, 422340 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 60359196, 61979798, 64928499, 69756377 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 310741, 310744, 310747, 310750 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 21569, 21947, 23158, 24514, 55531 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1179057G1021, 1179057G2028 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1078597, 1078598, 1078599, 1078600, 1078601, 1078602, 1078603, 1078604, 1078605 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 135321, 135348, 135356, 135364 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100090715, 100126175, 100157974, 100236001 |
| Country: US | FDA, National Drug Code | Identifier(s): 54092-513, 54092-515, 54092-517, 54092-519 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
